iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ITOS iTeos Therapeutics

休市中 12-20 16:00:00 EST

7.42

+0.20

+2.77%

盘后7.45

+0.03+0.41%

19:29 EST

最高7.51	最低7.09	成交量244.40万
今开7.17	昨收7.22	日振幅5.82%
总市值2.71亿	流通市值2.09亿	总股本3,653万
成交额1,793万	换手率8.68%	流通股本2,815万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ITOS","market":"US","secType":"STK","nameCN":"iTeos Therapeutics","latestPrice":7.42,"timestamp":1734728400000,"preClose":7.22,"halted":0,"volume":2443970,"hourTrading":{"tag":"盘后","latestPrice":7.4501,"preClose":7.42,"latestTime":"19:29 EST","volume":333303,"amount":2473114.27,"timestamp":1734740952508},"delay":0,"floatShares":28145832,"shares":36533918,"eps":-3.13917,"marketStatus":"休市中","marketStatusCode":7,"change":0.2,"latestTime":"12-20 16:00:00 EST","open":7.17,"high":7.51,"low":7.09,"amount":17932180.184520002,"amplitude":0.058172,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.13917,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1595563200000,"adjPreClose":7.22,"postHourTrading":{"tag":"盘后","latestPrice":7.4501,"preClose":7.42,"latestTime":"19:29 EST","volume":333303,"amount":2473114.27,"timestamp":1734740952508},"volumeRatio":5.303796,"impliedVol":2.319,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/ITOS","defaultTab":"news","newsList":[{"id":"2483640928","title":"Iteos Therapeutics, Inc.2024财年第三财季实现净利润-45.36百万美元，同比减少40.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483640928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483640928?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:02","pubTimestamp":1731542537,"startTime":"0","endTime":"0","summary":"11月14日，Iteos Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-45.36百万美元，同比减少40.69%；其中营业收入为0.00美元，每股基本收益为-1.05美元。从资产负债表来看，Iteos Therapeutics, Inc.总负债91.39百万美元，其中短期债务1.35百万美元，资产负债比为0.08，流动比率为0.15。机构评级：截至2024年11月14日，当前有5家机构对Iteos Therapeutics, Inc.目标价做出预测，其中目标均价为32.00美元，其中最低目标价为22.00美元，最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a2355971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a2355971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2481046602","title":"Iteos Therapeutics Inc  预计每股亏损 89 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481046602","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481046602?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:06","pubTimestamp":1730901987,"startTime":"0","endTime":"0","summary":"Iteos Therapeutics Inc  预计每股亏损 89 美分 - 财报前瞻) Iteos Therapeutics Inc ITOS.OQ ITOS.O预计在11月8日公布的截至0001年1月1日的业绩(，季度收入将有所增长。LSEG 分析师对 Iteos Therapeutics Inc 的平均预期是每股亏损 89 美分。华尔街对Iteos Therapeutics Inc的12个月目标价中位数为33.50美元，高于其最新收盘价9.22美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD2B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITOS"],"gpt_icon":0},{"id":"2480832108","title":"Iteos Therapeutics, Inc.盘中异动 快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480832108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480832108?lang=zh_cn&edition=full","pubTime":"2024-11-02 00:59","pubTimestamp":1730480372,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日00时59分，Iteos Therapeutics, Inc.股票出现波动，股价急速拉升5.33%。截至发稿，该股报8.90美元/股，成交量59.633万股，换手率1.63%，振幅5.21%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Theriva Biologics, Inc.涨幅较大，Theriva Biologics, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为3504.02%、890.00%、859.16%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、96.49%、60.77%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102005932a20a4e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102005932a20a4e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2478932530","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.12%报9.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478932530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478932530?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:26","pubTimestamp":1729866368,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时26分，Iteos Therapeutics, Inc.股票出现波动，股价快速拉升5.12%。截至发稿，该股报9.04美元/股，成交量7.5416万股，换手率0.21%，振幅4.77%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为720.21%、655.38%、158.47%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.，振幅分别为91.58%、77.79%、69.41%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222609a1eaa9f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222609a1eaa9f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2477986739","title":"Iteos Therapeutics, Inc.盘中异动 急速下跌5.09%报8.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477986739?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:17","pubTimestamp":1729523825,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时17分，Iteos Therapeutics, Inc.股票出现异动，股价快速跳水5.09%。截至发稿，该股报8.95美元/股，成交量23.3408万股，换手率0.64%，振幅4.24%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5703.11%、3001.05%、1290.23%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231705a1e24f5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231705a1e24f5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ","BK4139"],"gpt_icon":0},{"id":"2469416963","title":"Iteos Therapeutics, Inc.盘中异动 临近午盘快速下挫5.33%报10.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469416963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469416963?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:36","pubTimestamp":1727192211,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时36分，Iteos Therapeutics, Inc.股票出现异动，股价急速下跌5.33%。截至发稿，该股报10.04美元/股，成交量22.2285万股，换手率0.61%，振幅4.53%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为3935.01%、181.32%、127.21%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为101.84%、58.52%、45.08%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423365298e38b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092423365298e38b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2468847510","title":"BUZZ--美国股票走势-Charles Schwab、CACI International、Icahn Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468847510?lang=zh_cn&edition=full","pubTime":"2024-09-17 00:07","pubTimestamp":1726502845,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 科技股周一拖累了标普500指数和纳斯达克指数，因为在本周晚些时候美联储将做出关键的货币政策决定之前，市场谨慎情绪弥漫，大多数交易商认为借贷成本将大幅下降。美东时间11:31，道琼斯工业平均指数  上涨0.19%，报41,470.55点。标普500指数  下跌0.17%，报5616.5点；纳斯达克综合指数  下跌0.79%，报17544.279点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGM","SYF","CZR","UPST","LSCC","AVB","EOG","FDX","QLD","UDR","ALLY","SBT","ZNTL","ICE","ITOS","APA","CVX","UDOW",".SPX","COP","MNQmain","CACI","YELP","REE",".DJI","QID","COIN","KLXE","NQmain","WYNN","DPZ","EQR","HUT","LVS","DOG","CSLR","MOS","SCHW","SQQQ","BLDR","NUVL","IEP","ZG","DJX","ESS",".IXIC"],"gpt_icon":1},{"id":"2467384145","title":"BUZZ-肺癌药物中期研究结果公布后，伊泰奥斯公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2467384145","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467384145?lang=zh_cn&edition=full","pubTime":"2024-09-16 23:08","pubTimestamp":1726499320,"startTime":"0","endTime":"0","summary":" (更新)    9月16日 - ** 癌症药物开发商Iteos Therapeutics   股价下跌23.6%至12.76美元** 股价在盘前交易中一度上涨27.3%至21 .26美元 ** 该公司称，其肺癌药物belrestotug与葛兰素史克  的药物dostarlimab联用后，与只服用葛兰素史克药物的患者相比，肿瘤缩小或消失的比例更高。** 然而，与多司他单药治疗相比，联合用药导致免疫相关事件增加，ITOS说。** 该组合疗法在一种被称为非小细胞肺癌的晚期肺癌患者中进行了测试** 包括本交易日的走势在内，该股今年累计上涨了 16.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ITOS"],"gpt_icon":0},{"id":"2467848578","title":"BUZZ--美国股票走势-博士伦、美国铝业、加密股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2467848578","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467848578?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:21","pubTimestamp":1726492860,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 美国主要股指周一开盘涨跌不一，因为在美联储本周晚些时候将做出关键的货币政策决定之前，华尔街开始变得谨慎，大多数交易员认为借贷成本将大幅下调。美东时间9:04，道指电子盘  上涨0.21%，报41513 点。标普500指数小型股  下跌0.08%，报5625.5点；纳斯达克100指数小型股  下跌0.48%，报19436点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","ALLY","BK4007","NUVL","CL","MGM","BK4018","LU0980610538.SGD","BK4515","BK4550","EQR","ITOS","LU1153585028.USD","LU1883839398.USD","SG9999001176.USD","LU0052756011.USD","LU0081259029.USD","LU0323591593.USD","BK4504","HUT","LU0310800965.SGD","ICE","LVS","AA","LU1599440770.SGD","CZR","IE00B19Z3B42.SGD","AVB","LU2023250504.SGD","LU2237443382.USD","UPST","COIN","BLCO","BK4512","BK4503","WYNN","FDX","SG9999013999.USD","UDR","RIOT","BK4150","BLDR","LU1917777945.USD","ESS","ZNTL","ZG","LU0130517989.USD"],"gpt_icon":1},{"id":"2467814593","title":"BUZZ--美国股票走势-英特尔、高露洁-棕榄公司、Zillow 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2467814593","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467814593?lang=zh_cn&edition=full","pubTime":"2024-09-16 20:04","pubTimestamp":1726488246,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 美国股指期货周一表现低迷，因为在美联储本周晚些时候做出关键性货币政策决定之前，谨慎情绪占据上风，投资者预计借贷成本将大幅下降。美东时间7:35 ，道指电子盘  上涨0.22%，报41518点。标普500指数小型股  下跌0.06%，报5626.5点；纳斯达克100指数小型股  下跌0.40%，报19452点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUT","LU0321505868.SGD","LU0731783394.SGD","LU1675838814.USD","Z","BK4568","LU1153585028.USD","LU2237957811.SGD","LU0949170772.SGD","LU2463526074.USD","ALLY","BK4023","BK4561","LU1894683264.USD","IE00BLSP4452.SGD","LU1861559042.SGD","BK4153","BK4504","SG9999011175.SGD","LU0868494617.USD","INTC","LU1150488218.USD","SG9999003800.SGD","AA","LU0306806265.USD","LU1941712348.USD","LU1894683348.USD","LU0154245673.USD","ZG","LU2237957902.USD","BK4141","LU0225284248.USD","LU0456855351.SGD","LU0985320562.USD","LU1150488135.SGD","LU0225771236.USD","ICE","ITOS","CL","LU0306807586.USD","LU0122379950.USD","LU0323591593.USD","BK4547","BK4585","BK4588","LU0738911758.USD"],"gpt_icon":1},{"id":"2467560814","title":"BUZZ--美国股票走势-英特尔、高露洁-棕榄公司、Zillow 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2467560814","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467560814?lang=zh_cn&edition=full","pubTime":"2024-09-16 20:04","pubTimestamp":1726488246,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月16日 - 美国股指期货周一表现低迷，因为在美联储本周晚些时候做出关键性货币政策决定之前，谨慎情绪占据上风，投资者预计借贷成本将大幅下降。美东时间7:35 ，道指电子盘  上涨0.22%，报41518点。标普500指数小型股  下跌0.06%，报5626.5点；纳斯达克100指数小型股  下跌0.40%，报19452点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4547","LU1894683264.USD","AA","LU0321505868.SGD","LU0154245673.USD","BK4153","ICE","BK4588","LU2237957902.USD","LU0306806265.USD","LU1894683348.USD","LU0306807586.USD","LU0225771236.USD","LU0122379950.USD","ZG","ALLY","BK4504","LU0985320562.USD","LU0323591593.USD","HUT","IE00BLSP4452.SGD","BK4568","INTC","LU0225284248.USD","LU0456855351.SGD","LU0868494617.USD","LU0949170772.SGD","LU1150488135.SGD","LU2463526074.USD","Z","BK4585","CL","LU1675838814.USD","LU0731783394.SGD","BK4561","SG9999003800.SGD","LU1150488218.USD","LU2237957811.SGD","BK4141","LU0738911758.USD","LU1941712348.USD","ITOS","LU1153585028.USD","LU1861559042.SGD","SG9999011175.SGD"],"gpt_icon":1},{"id":"2467897732","title":"BUZZ-肺癌药物组合疗效优于葛兰素史克的简柏利（Jemperli）单药，Iteos公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2467897732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467897732?lang=zh_cn&edition=full","pubTime":"2024-09-16 17:27","pubTimestamp":1726478834,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月16日 - ** 癌症药物开发商Iteos Therapeutics   股价盘前上涨14.7%，报19.16美元** 该公司称，其肺癌药物belrestotug与葛兰素史克  的药物dostarlimab联合使用后，63.3%-76.7%的患者肿瘤缩小或消失，而只使用葛兰素史克药物的患者肿瘤缩小或消失的比例为37.5%。** 葛兰素史克公司的抗癌药物多司他利单抗以 Jemperli 品牌销售** 在一种被称为非小细胞肺癌的晚期肺癌患者中测试了这种组合药物** 截至上一交易日收盘，股价累计上涨 52.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ITOS","GSK.UK","GSK","BK4588","LU1829250122.USD","BK4532","BK4139","BK4585"],"gpt_icon":0},{"id":"2460868478","title":"Iteos Therapeutics, Inc.盘中异动 临近午盘股价大涨5.10%报16.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460868478","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460868478?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:39","pubTimestamp":1724168340,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日23时39分，Iteos Therapeutics, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报16.70美元/股，成交量7.5612万股，换手率0.21%，振幅4.22%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为3020.99%、2144.24%、344.56%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Biomotion Sciences C/Wts Exp 15/08/2029 ，振幅分别为269.86%、128.68%、78.89%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233900a1d53e84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233900a1d53e84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITOS","BK4139"],"gpt_icon":0},{"id":"2460066223","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460066223","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460066223?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:48","pubTimestamp":1724096897,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时48分，Iteos Therapeutics, Inc.股票出现波动，股价快速上涨5.09%。截至发稿，该股报15.70美元/股，成交量19.8063万股，换手率0.54%，振幅6.76%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Alzamend Neuro, Inc.、Nucana Plc、Virax Biolabs Group Limited涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为9500.14%、3925.70%、1344.02%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为456.88%、220.18%、198.02%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820034818ab5e7033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820034818ab5e7033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITOS","LENZ"],"gpt_icon":0},{"id":"2459716472","title":"Iteos Therapeutics, Inc.2024财年第二财季实现净利润-7.13百万美元，同比增加79.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459716472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459716472?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737775,"startTime":"0","endTime":"0","summary":"8月16日，Iteos Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-7.13百万美元，同比增加79.21%；其中营业收入为35.00百万美元，每股基本收益为-0.18美元。从资产负债表来看，Iteos Therapeutics, Inc.总负债87.97百万美元，其中短期债务1.28百万美元，资产负债比为0.09，流动比率为0.19。机构评级：截至2024年8月16日，当前有5家机构对Iteos Therapeutics, Inc.目标价做出预测，其中目标均价为31.60美元，其中最低目标价为21.00美元，最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160003149f2e44cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160003149f2e44cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"1179788463","title":"异动解读 | iTeos Therapeutics股价大涨7.24%,机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1179788463","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179788463?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:46","pubTimestamp":1723556778,"startTime":"0","endTime":"0","summary":"2024年8月13日,生物技术公司iTeos Therapeutics股价出现大涨,盘中一度上涨7.24%,引发市场广泛关注。分析人士认为,iTeos Therapeutics股价大涨或与机构投资者对该公司前景的看好有关。这表明机构投资者对公司的长期发展前景持乐观态度。iTeos Therapeutics是一家专注于免疫肿瘤学领域的生物制药公司,其主要产品包括EOS-850和EOS-448等,旨在通过恢复针对癌症的免疫反应来改善临床结果。随着公司产品线的不断丰富和临床进展,市场对其长期增长潜力充满期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITOS"],"gpt_icon":0},{"id":"2459909470","title":"Iteos Therapeutics, Inc.盘中异动 急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459909470","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459909470?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:34","pubTimestamp":1723556082,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时34分，Iteos Therapeutics, Inc.股票出现异动，股价大幅拉升5.17%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。消息层面，截至21时34分，Iteos Therapeutics, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132134439420044c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132134439420044c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":"    路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价，其中包括 Airbnb、Dollar General 和沃尔玛。要闻             * Airbnb Inc   ：杰富瑞将目标价从 150 美元下调至 125 美元              * Dollar General Corp   ：杰富瑞将目标价从160美元下调至145美元             * Hilton Grand Vacations Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc   ：摩根大通将目标价从45美元下调至10美元              * Pacira Biosciences Inc   ：Piper Sandler将目标价从42美元下调至11美元             * Pacira Biosciences Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGH","OKE","BK4173","BURL","BTAI","GHLD","ITOS","ROK","CARG","ARDT","DG","HLMN","GSHD","NTLA","RDFN","RDNT","HGV","HSIC","LU2361045086.USD","NNI","CBUS","BK4175","BJ","OPAD","LU1066051225.USD","STEP","PX","HBI","EWTX","CCOI","WMT","BWIN","LU2361044865.SGD","ABNB","IE0034390439.USD","FMC","SKY","LU1069347547.HKD","ZD","FTDR","DLTR","GCMG","CC","LU2361044949.HKD","BK4535","EXPE","PCRX","SWIM","LU0211327993.USD"],"gpt_icon":1},{"id":"2457731910","title":"Iteos Therapeutics, Inc.盘中异动 早盘快速跳水6.04%报14.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457731910","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457731910?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:41","pubTimestamp":1723124519,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时41分，Iteos Therapeutics, Inc.股票出现异动，股价大幅下跌6.04%。截至发稿，该股报14.30美元/股，成交量5239股，换手率0.01%，振幅4.99%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oragenics Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为223.79%、220.50%、62.96%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Anew Medical, Inc.，振幅分别为57.58%、40.44%、24.77%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214159968252ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808214159968252ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0},{"id":"2456280350","title":"Iteos Therapeutics Inc    预计每股亏损 1.04 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456280350","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456280350?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:16","pubTimestamp":1722608189,"startTime":"0","endTime":"0","summary":"   * Iteos Therapeutics Inc    预计在8月6日公布的截至0001年1月1日的业绩报告(估计)，季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司预计将实现100万美元的营收。* LSEG 分析师对 Iteos Therapeutics Inc 的平均预期是每股亏损 1.04 美元。* 华尔街对 Iteos Therapeutics Inc 的 12 个月目标价中位数为 41.00 美元，高于其上次收盘价 17.46 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ITOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iteostherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0339},{"period":"1month","weight":-0.0548},{"period":"3month","weight":-0.341},{"period":"6month","weight":-0.4986},{"period":"1year","weight":-0.2879},{"period":"ytd","weight":-0.3224}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iTeos Therapeutics, Inc.根据特拉华州法律于2019年10月4日成立。该公司是临床阶段的生物制药公司，率先发现和开发了面向患者的新一代高度分化的免疫肿瘤疗法。该公司利用他们对肿瘤微环境和免疫抑制途径的深刻理解来设计新的候选药物，目的是提高肿瘤治疗的临床疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.07212},{"month":2,"riseRate":0.5,"avgChangeRate":0.052436},{"month":3,"riseRate":0.25,"avgChangeRate":-0.061307},{"month":4,"riseRate":0.25,"avgChangeRate":-0.171458},{"month":5,"riseRate":0.5,"avgChangeRate":0.068217},{"month":6,"riseRate":0.5,"avgChangeRate":0.031423},{"month":7,"riseRate":0.75,"avgChangeRate":0.092866},{"month":8,"riseRate":0.4,"avgChangeRate":0.075236},{"month":9,"riseRate":0,"avgChangeRate":-0.164906},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063472},{"month":11,"riseRate":0.8,"avgChangeRate":0.094564},{"month":12,"riseRate":0.6,"avgChangeRate":0.117666}],"exchange":"NASDAQ","name":"iTeos Therapeutics","nameEN":"iTeos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iTeos Therapeutics,ITOS,iTeos Therapeutics股票,iTeos Therapeutics股票老虎,iTeos Therapeutics股票老虎国际,iTeos Therapeutics行情,iTeos Therapeutics股票行情,iTeos Therapeutics股价,iTeos Therapeutics股市,iTeos Therapeutics股票价格,iTeos Therapeutics股票交易,iTeos Therapeutics股票购买,iTeos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}